Using CRISPR/Cas9 technology, a T>G mutation was created in the FVB strain, converting a deleterious mutation (SNP rs13477613) in FVB (and A/J) to the reference, non-pathogenic, sequence of the B6 strain. This results in a serine codon in FVB changing to the B6 arginine codon. (J:282171)